3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms
216
Stomach Neoplasms
166
Rectal Neoplasms
146
Pancreatic Neoplasms
81
Colonic Neoplasms
77
Neoplasm Metastasis
67
Esophageal Neoplasms
55
Neoplasms
31
Adenocarcinoma Of Esophagus
29
Cholangiocarcinoma
28
Carcinoma, Hepatocellular
26
Adenocarcinoma
26
Biliary Tract Neoplasms
23
Lymphoma, Large B-Cell, Diffuse
19
Recurrence
17
Carcinoma, Non-Small-Cell Lung
16
Gallbladder Neoplasms
14
Breast Neoplasms
14
Head and Neck Neoplasms
11
Locally Advanced Rectal Cancer
10
Liver Neoplasms
10
Gastrointestinal Neoplasms
10
Esophageal Squamous Cell Carcinoma
9
Peritoneal Neoplasms
8
Ovarian Neoplasms
8
Colorectal Cancer Metastatic
7
Bile Duct Neoplasms
6
Urinary Bladder Neoplasms
5
Lymphoma, Non-Hodgkin
5
Lymphoma, Extranodal NK-T-Cell
5
Interventions
alvimopan
2
Oxaliplatin
2
Capecitabine
2
pembrolizumab
1
alectinib
1
Ocoxin
1
Folfox protocol
1
Cyclophosphamide
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Intestinal Diseases
×
Oxaliplatin
×
Clear all
NCT04080843
2022-07-13
ALTER-C-002
Zhejiang University
Phase 2
Completed
30 enrolled
NCT03280407
2017-09-28
NEOLAR
Zealand University Hospital
Phase 2
Unknown
124 enrolled